The hypothesis that there is a highly conserved, positively charged region distal to the second transmembrane domain in ␣-ENaC (epithelial sodium channel) that acts as a putative receptor site for the negatively charged COOH-terminal ␤-and ␥-ENaC tails was tested in mutagenesis experiments. After expression in Xenopus oocytes, ␣-ENaC constructs in which positively charged arginine residues were converted into negatively charged glutamic acids could not be inhibited by blocking peptides. These observations provide insight into the gating machinery of ENaC.
Liddle mutant; amiloride; inside-out patch; voltage clamp; post-M2 region LIDDLE'S SYNDROME is a form of hereditary hypertension produced by mutations within the epithelial sodium channel (ENaC) (1, 17) . These mutations result in constitutive channel activation. Both an increase in functional channel number and an increase in singlechannel open probability (P o ) have been reported (5-9, 14, 15) . The initial description of Liddle's syndrome identified truncation mutations in the COOH-terminal polypeptide chain of the ␤-ENaC (and subsequently the ␥-ENaC) subunit as being causative for constitutive channel activation (3, 5-9, 14, 15) . We proposed the hypothesis that the COOH-terminal chains of ␤ and ␥ could act as intrinsic channel blockers by serving as an inactivation moiety. Our evidence, obtained in both bilayers (7, 8) and heterologous expression systems (9) , supports this type of mechanism. We tested the hypothesis that the functional gating particle comprised the COOH-terminal tails of both the ␤-and ␥-ENaC subunits associated as a two-strand, antiparallel ␤-sheet. Support for this idea was threefold: 1) the inhibitory effects of adding COOH-terminal ␤-and ␥-ENaC 30-amino acid residue peptides together with ENaC comprising wild-type ␣-and COOH-terminally truncated ␤-and ␥-subunits produced a greater than additive inhibition of the channel; 2) circular dichroism studies showed that the 30-mer ␤ and ␥ peptides formed a ␤-sheet; and 3) when the isoleucines and valines within the 30-mer peptides were replaced by the ␤-sheet, breaking amino acids proline or aspartic acid, the resulting peptides were unable to affect basalactivated ENaC (8) . The paradigm that we have developed for ENaC gating is as follows. Because ␣-ENaC itself forms a functional sodium channel (4), there must be an intrinsic gating mechanism in ␣-ENaC alone. We hypothesized that calcium is intimately involved in this process and have presented evidence to this effect (2) . The overall gating properties of ␣-ENaC vs. ␣␤␥-ENaC in bilayers do not differ (7) . Because the elimination of the cytoplasmic COOH-terminal tails of either or both of the ␤-and ␥-subunits substantially increases single-channel P o (5-9), there must be at least two separate gating processes, one inherent to ␣-ENaC alone and one conferred onto the complex by the ␤-and ␥-subunits.
To further elucidate the mechanism underlying the COOH-terminal ␤-and ␥-ENaC tail block of ENaC, we tested the hypothesis that a highly conserved region following (or at the most distal end of) the second transmembrane domain (M2) in ␣-ENaC may act as a putative receptor region for the negatively charged COOH-terminal ␤-and ␥-ENaC tails and, thus, facilitate their interaction with the channel. We have identified a sequence of positively charged amino acids between residues 586 and 591 of human ␣-ENaC (613-624 of the rat ␣-ENaC ortholog) (10) that is identical in all five mammalian ␣-ENaC subunits cloned to date (rat, bovine, human, mouse, and guinea pig) and that is arginine rich (RRFRSRYWSPGR). This region is conserved in ␦-ENaC (RRLRRAWFSWPR) (16) but is not present in either the ␤-or ␥-ENaC subunit or in the ENaC-related Aplysia sodium channel that is gated by FMRF-amide (phenylalanine-methionine-argininephenylalanine) (12) . We hypothesized that this concentration of positive charge may form a site for electrostatic interaction of the negatively charged COOHterminal ␤ and ␥ tails and, thus, provide an anchoring point for the peptides somewhere near the internal channel mouth. The peptides may bind at a site away from the actual channel mouth but exert an inhibitory effect via steric hindrance or by inducing a conformational change. In the present experiments, we tested this hypothesis by mutating either two or four of the arginine residues in this sequence to amino acids of opposite charge. Our prediction was that the disruption of the charge distribution in this region would abolish the ability of the COOH-terminal ␤-and ␥-ENaC peptides to inhibit the channel.
We expressed the ␤-ENaC subunit truncated at amino acid R 564 (␤ R564X ) and the ␥-ENaC truncated at amino acid R 574 (␥ R574X ) in combination with the wild-type rat ␣-ENaC subunit (i.e., ␣␤ R564X ␥ R574X ) in Xenopus oocytes. Figure 1 shows representative amiloride-sensitive Na ϩ current traces obtained in voltage-clamped oocytes before and after 1 mM peptide mixture injection. In this series of experiments, the currents obtained from oocytes injected with wild-type ␣-ENaC and truncated ␤-and ␥-ENaC subunits were greater than the corresponding currents recorded from wild-type ␣␤␥-ENaC injected in oocytes obtained from the same frogs (data not shown). The average inward current levels were approximately twofold increased, as reported earlier (9) . Injection of a mixture of ␤ plus ␥ COOH-terminal peptides (SP 30 ␤ and SP 30 ␥; 1:1, 500 M each) into oocytes expressing the truncated ENaC constructs (i.e., ␣␤ R564X ␥ R5764X -ENaC) decreased the current by ϳ50% at negative potentials. In contrast, the currents in oocytes expressing either of the ␣ double mutations (i.e., ␣ R586E,R587E or ␣ R589E,R591E ) or the quadruple mutation in the ␣-subunit (␣ R586E,R587E,R589E,R591E ␤ R564X ␥ R574X ) were not affected by the same concentration of peptide mixture. As controls, the ␣␤ R564X ␥ R574X -ENaC associated current was not affected by water injection or by injection of SP 30 ␥ plus a 30-amino acid peptide identical to SP 30 ␤, with substitution of three prolines for one valine and two isoleucines (see Fig. 4 ). Summary data for the effect of the peptide mixture on wild-type ␣-subunit plus truncated ␤-and ␥-subunits, two double ␣ arginine mutations, and the quadruple mutation (all in combination with the truncated ␤-and ␥-subunits) are shown in Fig. 2 . Of these constructs, only the channel containing wild-type ␣-ENaC was inhibited by 1 mM peptide mixture. In contrast, both double mutants (namely, ␣ R586E,R587E and ␣ R589E,R591E ) and the quadruple mutant, in which the four positively charged arginines (R residues) were replaced with negatively charged Glu (E residues), were unaffected by injection of SP 30 ␤ plus SP 30 ␥ (Fig. 2) .
As further controls for these experiments, we made a series of ␣ mutations in the same position as the arginines, except that instead of changing the sign from positive to negative (glutamic acid), we maintained the same charge distribution by substitution with lysine (K). In an additional group of oocytes, 1 mM peptide added to ␣ R586K,R587K,R589K,R591K ␤ R564X ␥ R574X , ␣ R586K,R587K ␤ R564X ␥ R574X , or ␣ R589K,R591K ␤ R564X ␥ R574X inhibited macroscopic currents to the same extent as when added to the wild-type ␣-subunit. These data are supportive of the hypothesis that this arginine-rich region in the most distal portion of the M2 region plays a role in the interaction of the ␤-and ␥-subunit tails, causing inhibition of the channel.
We used single-channel analysis to explain more precisely the results that we obtained with these COOH-terminal peptides in macroscopic current measurements in heterologously expressing oocytes. Figure 3 shows representative single-channel current Fig. 1 . Representative current traces showing the effects of a 30-mer peptide mixture injection into Xenopus oocytes on amiloride-sensitive Na ϩ currents produced by various mutated ␣-ENaC (epithelial sodium channel) constructs (left). Records were made 24 h after cRNA injection for all groups of oocytes. Test voltages were stepped from a holding potential of 0 mV to Ϫ100 through ϩ 100 mV in a 10-mV increment, and each step was held for 500 ms. Right: effects of peptide mixture (total concentration 1 mM; 500 M each of SP30␤ and SP30␥) on currents. Each experiment was repeated at least 3 times.
traces for ␣␤ R564X ␥ R574X , the two double ␣ arginine mutants, and the quadruple mutant in combination with the truncated ␤-and ␥-subunits. The unitary conductances of all of these combinations of mutated and truncated ENaCs averaged 7 pS, demonstrating that there was no effect on the single-channel conductances by introduction of these mutations in the ␣-ENaC subunit. The peptide mixture only inhibited the single-channel activity (NP o ) of the wild-type ␣ construct (Fig. 3, horizontal bar above traces) . The peptide mixture was without effect in either of the double Glu (R3 K) ␣ mutants or in the quadruple Glu (R3 E) ␣ mutant. The value of NP o was decreased to 1.27 Ϯ 0.3 by the peptide mixture from 2.67 Ϯ 0.4 in patches isolated from oocytes expressing ␣␤ R564X ␥ R574X -ENaC. In contrast, the value of NP o recorded from excised patches with the quadruple mutant was unchanged following peptide exposure (2.91 Ϯ 0.4 and 2.89 Ϯ 0.3). In contrast, the values of NP o before and after addition of the control peptide mixture were 1.02 Ϯ 0.19 and 1.14 Ϯ 0.22 (n ϭ 3, Fig. 4 ).
These direct biophysical measurements of single ENaC demonstrate directly that the COOH-terminal regions of the ␤-and ␥-ENaC subunits function as intrinsic gating particles and that the interaction site occurs at an arginine-rich region located at the most distal portion of the M2 segment of the ␣-ENaC subunit. Thus these terminal cytoplasmic domains of ␤-and ␥-subunits play an important role in ENaC gating. Horizontal bars above the current traces indicate perfusion of the bath with 1 mM SP30␤ ϩ SP30␥ peptide mixture. The pipette medium consisted of 100 mM lithium chloride, and 100 mM lithium chloride was also included in the bath solution. The pH of the medium was adjusted to 7.4 with HEPES buffer at 23°C. The holding potential was Ϫ60 mV for each trace.
EXPERIMENTAL PROCEDURES
Construction of ␣-ENaC mutations. Full-length human ␣␤␥-ENaC cDNA was a gift from Dr. Michael J. Welsh (University of Iowa) (13) , and truncated ␤-and ␥-ENaC cDNAs were a gift from Dr. Bernard Rossier (Université et Lausanne, Switzerland) (14) . Point mutations in the ␣-subunit were constructed by using the QuickChange mutagenesis kit (Stratagene, La Jolla, CA). Each set of primers contained the appropriate base changes required to code for either two or four glutamates instead of the wild-type arginine residues. Plasmid cDNA, PCR, in vitro transcription, and bacterial transformation were all done as described previously (11) . cDNA products containing the specific mutations were confirmed by dideoxy sequence analysis as well.
Oocyte preparation and electrophysiological recording. Oocytes were removed from anesthetized adult female Xenopus laevis (Xenopus Express, Beverly Hills, FL) by standard technique (9) . Follicle cells were removed in OR-2 calcium-free medium (in mM: 82.5 NaCl, 2.5 KCl, 1.0 MgCl 2 , 1.0 Na 2 HPO 4 , and HEPES 5.0, pH 7.5), with the addition of collagenase. Defolliculated oocytes were washed in both OR-2 (calcium-free) and OR-2 (complete) medium (in mM: 82.5 NaCl, 2.5 KCl, 1.0 MgCl 2 , 1.0 CaCl 2 , 1.0 Na 2 HPO 4 , and HEPES 5.0, pH 7.4) and allowed to recover overnight in half-strength Liebovitz's medium at 18°C. Stage VI oocytes were injected with 50 nl (8.3 ng of the appropriate ␣-, ␤-, and ␥-ENaC cRNA construct; all subunit mixtures were 1:1:1). Two-electrode voltage clamp and/or single-channel measurements were made 24-48 h postinjection as described previously (9) . Oocytes were clamped at a holding potential of 0 mV. The current-voltage relationships were acquired by stepping the holding potential in 10-mV increments from Ϫ100 to ϩ100 mV. Current-voltage data were recorded after the monitoring currents were stable, before and after the application of 10 M amiloride to the bath. Data were sampled at a rate of 1 kHz and filtered at 500 kHz. Data analysis was also as described previously (9) . Analysis of single-channel data was performed by using FETCHAN and pSTAT programs of pCLAMP version 8.0 software (Axon Instruments, Burlingame, CA) as previously described (9) .
Peptide synthesis and purification. Peptides were synthesized by ResGen (Huntsville, AL). After synthesis, the peptides were subjected to reversed-phase, high-performance liquid chromatography to increase their purity to Ͼ90%. Only a single peak was observed on the final chromatograph. The peptides were analyzed for amino acid composition by mass spectroscopy. The sequences for the COOH-terminal 30-amino acidlong ␤-ENaC (SP 30 ␤) and ␥-ENaC (SP 30 ␥) peptides were as follows: SP 30 ␤, PIPGTPPPNYDSLRLQPLD-VIESDSEGDAI; and SP 30 ␥, PGTPPKYNTLRLERAF-SNQLTDTQMLDEL.
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